FDA Approval For Rafa’s Life-saving Midazolam Autoinjector for US DoD’s Advanced Anticonvulsant System Program
Jerusalem-based Rafa Laboratories LTD. ("Rafa") is pleased to announce the U.S. Food and Drug Administration has approved its "first in market" 10 mg midazolam autoinjector for the treatment of status…
Continue Reading
FDA Approval For Rafa’s Life-saving Midazolam Autoinjector for US DoD’s Advanced Anticonvulsant System Program